Macro- and microvascular alterations in patients with metabolic syndrome: Sugar makes the difference

Hypertension Research

Volumn 37, Issue 5, 2014, Pages 452-456

  Pietri, Panagiota ^a   Vlachopoulos, Charalambos ^a   Vyssoulis, Gregory ^a   Ioakeimidis, Nikolaos ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

arterial stiffness; cardiovascular risk; glucose metabolism; metabolic syndrome; microalbuminuria

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD VESSEL INJURY; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART RATE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY FUNCTION; MACROVASCULAR DAMAGE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; MICROVASCULAR DAMAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE; AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; GLUCOSE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84899797898     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.148     Document Type: Article

References (39)

1. Dekker J, Girman C, Rhodes T, Nijpels G, Stehouwer C, Bouter L, Heine R. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005; 112: 666-673
2. Lakka H-M, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Toumilehto J, Salonen J. The metabolic syndrome and total and cardiovascular disease mortality in middle-Aged men. JAMA 2002; 288: 2709-2726
3. McNeill AM, Rosamond W, Girman S, Golden SH, Schmidt M, East H, Ballantyne C, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385-390
4. Scuteri A, Najjar S, Morrell C, Lakatta E. The metabolic syndrome in older individuals: Prevalence and prediction of cardiovascular events. The Cardiovascular Health Study. Diabetes Care 2005; 28: 882-887
5. Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: A 13-year follow-up study in elderly nondiabetic Finns. Eur Heart J 2007; 28: 857-864
6. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 2007; 30: 2381-2387
7. Ridker P, Buring J, Cook N, Rifai N. C-reactive protein, the metabolic syndrome and risk of incident cardiovascular events. Circulation 2003; 107: 391-397
8. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly D, Haffner S, Isles C, Macfarlane P, Packard C, Cobbe S, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419
9. Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E. Cardiovascular death and the metabolic syndrome. Role of adiposity-signaling hormones and inflammatory markers. Diabetes Care 2006; 29: 1363-1369
10. Anand S, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S. For the Study of Health Assessment and Risk in Ethnic groups (SHARE) and Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP) Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420-425
11. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. J Am Coll Cardiol 2010; 55: 1318-1327
12. Cruickshank K, Riste L, Anderson S, Wright J, Dunn G, Gosling R. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance. Circulation 2002; 106: 2085-2090
13. Vyssoulis GP, Pietri PG, Karpanou EA, Vlachopoulos CV, Kyvelou SM, Spanos P, Cokkinos DV, Stefanadis CI. Differential impact of metabolic syndrome on arterial stiffness and wave reflections: Focus on distinct definitions. Int J Cardiol 2010; 138: 119-125
14. Schillaci G, Pirro M, Vaudo G, Mannarino M, Savarese G, Pucci G, Franklin S, Mannarino E. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 2005; 45: 1078-1082
15. Czernichow S, Bertrais S, Blacher J, Oppert J-M, Galan P, Ducimetièr P, Hercberg S, Safar S, Zureik M. Metabolic syndrome in relation to structure and function of large arteries: A predominant effect of blood pressure. A report from the SU.VI.MAX Vascular Study. Am J Hypertens 2005; 18: 1154-1160
16. Mulè G, Cottone S, Mongiovì R, Cusimano P, Mezzatesta G, Seddio G, Volpe V, Nardi E, Andronico G, Piazza G, Cerasola G. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr Metab Cardiovasc Dis 2006; 16: 54-59
17. Scuteri A, Najjar S, Muller D, Andres R, Hougaku H, Metter J, Lakatta E. Metabolic syndrome amplifies the age-Associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43: 1388-1395
18. Ferreira I, Boreham C, Twisk J, Gallagher A, Young I, Murray L, Stehouwer C. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: The Northern Ireland Young Heart Project. J Hypertens 2007; 25: 1009-1020
19. Protogerou A, Blacher J, Aslangul E, Le Jeunne C, Lekakis J, Mavrikakis M, Safar M. Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis 2007; 193: 151-158
20. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18
21. Gerstein H, Mann J, Yi Q, Dinneen S, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf Sfor the HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553
23. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannatasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. On behalf of the European Network for Non-invasive investigation of Large Arteries. Expert consensus document on arterial stiffness: Methological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605
24. Asmar R, Benetos A, Topouchian J, Laurent S, Pannier B, Brisac A-M, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement: Validation and clinical application studies. Hypertension 1995; 26: 485-490
25. Scuteri A, Najjar S, Orru M, Usala G, Piras MG, Ferrucci L, Cao A, Schlessinger D, Uda M, Lakatta E. The central arterial burden of the metabolic syndrome is similar in men and women: The SardiNIA Study. Eur Heart J 2010; 31: 602-613
26. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, Yamamoto Y, Yamashina A. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005; 45: 997-1003
27. Levy D, Hwang S-J, Kayalar A, Benjamin E, Vasan R, Parise H, Larson M, Wang T, Selhub J, Jacques P, Vita J, Keyes M, Mitchell G. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: The Framingham Heart Study. Circulation 2007; 115: 3079-3085
28. Bortolotto L, Safar M, Billaud E, Lacroix C, Asmar R, London G, Blacher J. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999; 34: 837-842
29. Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, Tsiachris D, Stefanadi E, Mihas C, Miliou A, Papademetriou V, Stefanadis C. ADMA, C-reactive protein and albuminuria in untreated essential hypertension: A cross-sectional study. Am J Kidney Dis 2010; 55: 1050-1059
30. Jager A, Kostense P, Nijpels G, Dekker J, Heine R, Bouter L, Donker A, Stehouwer C. Serum homocysteine levels are associated with the development of (micro)albuminuria. The Hoorn Study. Arterioscler Thromb Vasc Biol 2001; 21: 74-81
31. Pravenec M, Kajiya T, Zídek V, Landa V, Mlejnek P, Simáková M, Silhavy J, Malínská H, Oliyarnyk O, Kazdová L, Fan J, Wang J, Kurtz T. Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension 2011; 57: 731-737
32. Zhao Z, Nie H, He H, Yan Z, Liu D, Luo Z, Ma L, Ni Y, Chen J, Jing J, Cao T, Yang H, Tepel M, Zhang W, Zhu Z. High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome. Metabolism 2007; 56: 1612-1619
33. Pedrinelli R, Dell'Omo G, Di Bello V, Pellegrini G, Pucci L, Del Prato S, Penno G. Lowgrade inflammation and microalbuminuria in hypertension. Atheroscler Thromb Vasc Biol 2004; 24: 2414-2419
34. Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: Pathophysiological implication for microalbuminuria in hypertension. Hypertension 2011; 58: 839-846
35. O'Rourke M, Safar M. Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy. Hypertension 2005; 46: 200-204
36. Wang Y, Hu Y, Li Y, Chu S, Zhu D, Gao P. Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients. Hypertens Res 2012; 35: 201-206
37. Munakata M, Miura Y, Yoshinaga K. On behalf of the J-TOPP study group. Higher brachial-Ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: The J-TOPP study. J Hypertens 2009; 27: 1466-1471
38. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, Toutouza M, Stefanadis C. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005; 112: 2193-2200
39. Hingorani AD, Cross J, Kharbanda RK, Mullen M, Bhagat K, Taylor M, Donald AE, Palacios M, Griffin GE, Deanfield JE, Chir B, MacAllister RJ, Vallance P. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-999